|
Memantine. Merz.
Kilpatrick GJ, Tilbrook GS.
CeNeS Ltd, Compass House,
Vision Park,
Histon, Cambridge, UK.
gavin.kilpatrick@cenes.co.uk
Curr Opin Investig Drugs 2002 May;3(5):798-806
Abstract
Memantine hydrochloride, an NMDA antagonist, was launched in Germany by Merz in 1989 for the treatment of dementia, an indication for which development was continuing in other markets. It is also under development by Merz, Lundbeck, Neurobiological Technologies Inc (NTI) Forest Laboratories and Suntory for the potential treatment of Alzheimer's disease (AD), AIDS-related dementia and pain in patients with neuropathy, and by Allergan for the potential treatment of ocular disease. By July 2001, a regulatory filing for neuropathic pain was expected in 2003. In February 2002, the CPMP recommended to the EU commission to approve memantine for the treatment of moderately severe-to-severe Alzheimer's disease. At this time, marketing authorization was expected late in the first half of 2002, and Lundbeck planned to launch memantine under the brand name Ebixa during the second half of 2002. Merz and Lundbeck, filed memantine for AD in the EU in September 2000 and an NDA was submitted in November of that year. The compound was in phase H trials in the US for the treatment of AIDS-related dementia and pain by August 1996 and phase III trials for glaucoma and neuroprotection by 1999. Analysts at Merrill Lynch predicted in October 2001 that Allergan would make regulatory filings in the US for memantine in glaucoma and ocular hypertension in 2005, and that Forest Laboratories would file for memantine in the US as a supplement to Alzheimer's disease data in early 2002, and for the treatment of neuropathic pain in 2003. Sales of $25 million in 2004, rising to $75 million in 2005, were predicted by Merrill Lynch for this product.
|
|
|
order |
www.AlzheimersTreatments.com
|
Galantamine Alzheimer's
articles
Galantamine fights Alzheimer's
In
the 1950s, a Bulgarian pharmacologist noticed that local villagers rubbed their
foreheads with
the snowdrop plant to ease
nerve pain. Further investigation led to the isolation of the snowdrop extract
galantamine continue
Galantamine: why galantamine is the best agent for restoring memory
Galantamine has several advantages over donepezil (Aricept®) and rivastigmine (Exelon®)
continue
Galantamine: can sharpen your mental edge
Galantamine's positive results
in slowing the progression of Alzheimer's disease may be due continue
Galantamine: helps save Memory
Galantamine is used in treating Alzheimer's disease, because of its ability
continue
Galantamine: beats Prescription Drugs for
combating Mental Decline
Galantamine is different from donepezil (Aricept®) and rivastigmine (Exelon®) in one very important
way, galantamine has the unique ability to increase the receptiveness of nicotinic
receptors to acetylcholine continue
Galantamine: opens the channels of your Memory
The secret
of galantamine's success lies in your brain's nicotinic receptors. continue
Galantamine: Protect Brain Function by Enhancing Neurotransmission
Galantamine has been found to be effective in treating Alzheimer's
disease continue
Galantamine:
Boost Memory
Galantamine achieves the same effect as drugs such as
Aricept or tacrine, but has additional benefits continue
Galantamine protects Brain funtion
The
primary objective with
Alzheimer's is to enhance neurotransmission so as to retain memory continue
Galantamine:
food for Mind & Body
Galantamine is a
flower extract that improves memory and perhaps even helps with impotence continue
Galantamine may help stave off Dementia
Dementia
is a progressive loss of memory accompanied by significant continue
Galantamine: Memory Enhancement
Alzheimer's patients suffer sharp declines in their brain levels of acetylcholine.
Galantamine continue
Galantamine rescues
Brain Cells
According to a study of 653 Alzheimer's disease
patients published in the
British Medical Journal, the herbal supplement galantamine
"appears to slow the progression of the neurodegenerative
condition" continue
Galantamine:
the Old Become Young
As we age, it becomes harder to
learn new things. One explanation is the deterioration of the brain's
continue
Galantamine: What's Old with Acetylcholine is New to Us
Acetylcholine
deficiency is
characteristic of Alzheimer's disease. The primary treatment is administration
of agents like galantamine, an extract from the snowdrop and
daffodil plants continue
|
| |
|